The global immunohematology market is expected to reach a value of USD 2.3 billion by 2024, according to a new report by Grand View Research, Inc. This expansion is attributed to the increasing cases of trauma and rising number of hospital and trauma care centers facilitating emergency treatments. This creates a need to procure blood to suffice the demand, thus, boosting the market for immunohematology tests and products.Involvement of government organizations and NGOs is vast in this field.
Use of technology is contributing to the growth in the market. Use of mobile applications helps in tracking the blood donation activity of volunteer donors and also reminds them to donate regularly. In April 2016, The Indian Red Cross Society launched an application (app) to facilitate blood banking facility. The app is expected to address the shortage issue in the region. Moreover, in 2011, the first type of this application was launched by Hemo bioscience, Inc., a U.S.-based company. The company made the app available for free for apple users.
View
summary of this report @ http://www.grandviewresearch.com/industry-analysis/immunohematology-market
Further Key Findings From the Study Suggest:
·
Immunohematology reagents dominated the product
segment in 2015 due to huge product variety and an increasing number of blood
banks procuring these reagents. The innovations in the field are resulting in
new product launches and also the efforts are acknowledged at a global level.
·
In December 2013, Sysmex Corporation received
the German Design Award for its XN-2000 hematology reagent. Almost 1,900
products were nominated for the award.
·
Hospitals dominated the end-use segment in 2015
due to increasing number of emergency cases because of road accidents and other
types of trauma. Governments and investors are increasingly investing in
expanding and upgrading emergency departments in hospitals to cater to the
growing demand and increase the chances of survival of trauma patients.
·
In 2015, North America dominated the market with
a revenue share of more than 40%. In the U.S., there is a patient requiring
transfusion every 2 seconds. The daily consumption of blood is approximately
36,000 units per day. This indicates the huge opportunity of growth in this
region.
·
Some of the key industry players are Hologic,
Inc., Bio-Rad Laboratories, Inc.; Grifols, ThermoFisher, Immucor; Ortho
Clinical Diagnostics; BD (Becton Dickinson); Siemens Healthcare GmbH; Abbott;
and Beckman Coulter, Inc.
Browse
more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the immunohematology market by product, enduse, and region:
Immunohematology Product Outlook (Market revenue in USD Million, 2013 - 2024)
·
Immunohematology analyzer
·
Immunohematology reagent
Immunohematology End-Use Outlook (Market revenue in USD Million,
2013 - 2024)
·
Hospitals
·
Blood banks
·
Diagnostic laboratories
Immunohematology Regional Outlook (Market Revenue in USD Million,
2013 - 2024)
·
North America
o
U.S.
o
Canada
·
Europe
o
UK
o
Germany
·
Asia Pacific
o
Japan
o
China
·
Latin America
o
Brazil
o
Mexico
·
Middle East and Africa
o
South Africa
For press release of this report - http://www.grandviewresearch.com/press-release/global-immunohematology-market
No comments:
Post a Comment